Results for “ ”

Entry Author Date Location
East Coast Bio Roundup: CRISPR, Tessier-Lavigne, Pricing, Spero & More 02/05/16 Boston
Blood Simple? Grail’s Cancer Screening Quest Faces Tough Questions 02/04/16 National
ViaCyte Reports on Stem Cell Diabetes Trial, Absorbs BetaLogics 02/04/16 San Diego
BioDirection Scoops Up $4M for 90-Second Diagnostic of Concussions 02/03/16 Boston
Unity Bio Wants To “Lengthen Health Span,” But 1st Goals More Modest 02/03/16 San Francisco
CRISPR Hits Wall Street as Editas Bags $94M in IPO 02/02/16 Boston
Spero Eyes First Trial, Gets $30M More to Battle Drug-Resistant Bugs 02/02/16 Boston
Early Bird Special Ends Today for New York’s Life Science Disruptors 02/02/16 New York
Atlas5D Snags $3M For Sensor Devices That Balance Data & Privacy 02/01/16 Boston
East Coast Biotech Roundup: Editas, Hep C, Akashi, Tarveda & More 01/29/16 Boston
Blend Rebrands as Tarveda, Raises $38M, and Spins Out Cancer Drug 01/27/16 Boston
Safety Issues Spur Foundation-Backed Akashi to Suspend Duchenne Trial 01/26/16 Boston
Ex-Biogen Exec’s New Startup Gets $61M More For Exosome Drugs 01/26/16 Boston
As Markets and Controversies Swirl, Editas Aims For $100M CRISPR IPO 01/25/16 Boston
East Coast Biotech Roundup: Alkermes, Zafgen, Snowmaggedon & More 01/22/16 Boston
NYC’s Disruptive Biotech Startups take the Stage on March 29 01/21/16 New York
Depression Trials Fail, Alkermes Sees Silver Lining. Investors Don’t. 01/21/16 Boston
Some Good News, Finally, for Zafgen’s Obesity Drug 01/20/16 Boston
Same Twist, New Funding: Gene Synthesizer Raises $61M Series D 01/19/16 San Francisco
With Second Eye Drug Flop, Eleven Heads Back to Drawing Board 01/19/16 Boston
Acorda Doubles Down on Parkinson, Buys Biotie For $363M 01/19/16 New York
Love ‘Em? Hate ‘Em? No Matter. The Drug Industry Gets What It Wants. 01/19/16 National
Grail’s Discount, Pfizergan & Pricing Plans: Notes from the JPM Vortex 01/15/16 National
FDA Rejects BioMarin’s Duchenne Drug, Sarepta Up Next 01/14/16 San Francisco
Eyeing First Trials, Syros Brings in $40M and More Crossovers 01/13/16 Boston
Seres Inks Nestlé As Potential $2B Partner; Key Microbiome Data Soon 01/11/16 Boston
With Tensha Purchase, Roche Interest in Bradner Startups Continues 01/11/16 Boston
Warp Drive, Surface, Bamboo Cut Deals on Eve of J.P. Morgan 01/11/16 Boston
Accelerator, Gates Team Up in NY to Put $17M Into Rockefeller Startup 01/10/16 New York
East Coast Bio Roundup: NY Startups, Editas, Bonney, C4 & (Much) More 01/08/16 Boston
Page 1 of 272 next page »